Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Clinical trial NCT00068666 · TERMINATED

Trial details

NCT number: NCT00068666
Sponsor: Alliance for Clinical Trials in Oncology
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Metastatic Cancer

Start date: 2004-01-01
Primary completion: 2005-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.